Andrea Wan

647 total citations
18 papers, 549 citations indexed

About

Andrea Wan is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine and Cell Biology. According to data from OpenAlex, Andrea Wan has authored 18 papers receiving a total of 549 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 8 papers in Cardiology and Cardiovascular Medicine and 7 papers in Cell Biology. Recurrent topics in Andrea Wan's work include Proteoglycans and glycosaminoglycans research (7 papers), Metabolism, Diabetes, and Cancer (6 papers) and Cardiovascular Function and Risk Factors (5 papers). Andrea Wan is often cited by papers focused on Proteoglycans and glycosaminoglycans research (7 papers), Metabolism, Diabetes, and Cancer (6 papers) and Cardiovascular Function and Risk Factors (5 papers). Andrea Wan collaborates with scholars based in Canada, Israel and China. Andrea Wan's co-authors include Brian Rodrigues, Prasanth Puthanveetil, Dahai Zhang, Amy P. Chiu, Israël Vlodavsky, Ying Wang, Fulong Wang, Yoshitha A. Wanniarachchi, Piotr Kaczmarek and Elizabeth M. Nolan and has published in prestigious journals such as Biochemistry, Diabetes and Arteriosclerosis Thrombosis and Vascular Biology.

In The Last Decade

Andrea Wan

18 papers receiving 541 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Andrea Wan Canada 13 307 201 98 98 82 18 549
Ken Ho Australia 6 142 0.5× 81 0.4× 304 3.1× 116 1.2× 26 0.3× 10 492
C. Copin France 10 190 0.6× 81 0.4× 115 1.2× 48 0.5× 22 0.3× 11 428
Edwin Yoo United States 10 183 0.6× 100 0.5× 20 0.2× 208 2.1× 30 0.4× 18 539
Ronald Vlasblom Netherlands 8 223 0.7× 245 1.2× 54 0.6× 114 1.2× 35 0.4× 10 562
Tetsuya Kibe Japan 10 262 0.9× 37 0.2× 19 0.2× 158 1.6× 22 0.3× 23 484
Gengyun Sun China 15 321 1.0× 37 0.2× 20 0.2× 42 0.4× 34 0.4× 35 519
Élise Roussel Canada 17 246 0.8× 487 2.4× 45 0.5× 111 1.1× 197 2.4× 32 841
Guo-Ping Tian China 10 187 0.6× 69 0.3× 29 0.3× 20 0.2× 9 0.1× 24 475
James W. Gallagher United States 11 176 0.6× 211 1.0× 187 1.9× 116 1.2× 47 0.6× 15 607

Countries citing papers authored by Andrea Wan

Since Specialization
Citations

This map shows the geographic impact of Andrea Wan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrea Wan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrea Wan more than expected).

Fields of papers citing papers by Andrea Wan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andrea Wan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrea Wan. The network helps show where Andrea Wan may publish in the future.

Co-authorship network of co-authors of Andrea Wan

This figure shows the co-authorship network connecting the top 25 collaborators of Andrea Wan. A scholar is included among the top collaborators of Andrea Wan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andrea Wan. Andrea Wan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Wan, Andrea, et al.. (2023). Valproic Acid–Associated Hyperammonemia. Journal of Clinical Psychopharmacology. 43(3). 283–294. 6 indexed citations
2.
Chiu, Amy P., et al.. (2017). Dual effects of hyperglycemia on endothelial cells and cardiomyocytes to enhance coronary LPL activity. American Journal of Physiology-Heart and Circulatory Physiology. 314(1). H82–H94. 12 indexed citations
3.
Chiu, Amy P., Fulong Wang, Dahai Zhang, et al.. (2017). Loss of VEGFB and its signaling in the diabetic heart is associated with increased cell death signaling. American Journal of Physiology-Heart and Circulatory Physiology. 312(6). H1163–H1175. 28 indexed citations
4.
Wan, Andrea & Brian Rodrigues. (2016). Endothelial cell–cardiomyocyte crosstalk in diabetic cardiomyopathy. Cardiovascular Research. 111(3). 172–183. 67 indexed citations
5.
Chiu, Amy P., Andrea Wan, & Brian Rodrigues. (2016). Cardiomyocyte-endothelial cell control of lipoprotein lipase. Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids. 1861(10). 1434–1441. 6 indexed citations
6.
Zhang, Dahai, Fulong Wang, Amy P. Chiu, et al.. (2016). Heparanase Overexpression Induces Glucagon Resistance and Protects Animals From Chemically Induced Diabetes. Diabetes. 66(1). 45–57. 13 indexed citations
7.
Wang, Fulong, Dahai Zhang, Amy P. Chiu, et al.. (2016). High glucose facilitated endothelial heparanase transfer to the cardiomyocyte modifies its cell death signature. Cardiovascular Research. 112(3). 656–668. 15 indexed citations
8.
Chiu, Amy P., Andrea Wan, Dahai Zhang, et al.. (2015). Cardiomyocyte VEGF Regulates Endothelial Cell GPIHBP1 to Relocate Lipoprotein Lipase to the Coronary Lumen During Diabetes Mellitus. Arteriosclerosis Thrombosis and Vascular Biology. 36(1). 145–155. 32 indexed citations
9.
Puthanveetil, Prasanth, Andrea Wan, & Brian Rodrigues. (2015). Lipoprotein lipase and angiopoietin-like 4 – Cardiomyocyte secretory proteins that regulate metabolism during diabetic heart disease. Critical Reviews in Clinical Laboratory Sciences. 52(3). 138–149. 11 indexed citations
10.
Wang, Fang, Dahai Zhang, Andrea Wan, & Brian Rodrigues. (2014). Endothelial Cell Regulation of Cardiac Metabolism Following Diabetes. Cardiovascular & Haematological Disorders - Drug Targets. 14(2). 121–125. 6 indexed citations
11.
Chiu, Amy P., Fulong Wang, Ying Wang, et al.. (2014). Endothelial cells respond to hyperglycemia by increasing the LPL transporter GPIHBP1. American Journal of Physiology-Endocrinology and Metabolism. 306(11). E1274–E1283. 17 indexed citations
12.
Wang, Ying, Amy P. Chiu, Fulong Wang, et al.. (2014). Endothelial Cell Heparanase Taken Up by Cardiomyocytes Regulates Lipoprotein Lipase Transfer to the Coronary Lumen After Diabetes. Diabetes. 63(8). 2643–2655. 22 indexed citations
13.
Wang, Fang, Andrea Wan, & Brian Rodrigues. (2013). The Function of Heparanase in Diabetes and its Complications. Canadian Journal of Diabetes. 37(5). 332–338. 18 indexed citations
14.
Wang, Ying, Dahai Zhang, Amy P. Chiu, et al.. (2013). Endothelial Heparanase Regulates Heart Metabolism by Stimulating Lipoprotein Lipase Secretion From Cardiomyocytes. Arteriosclerosis Thrombosis and Vascular Biology. 33(5). 894–902. 28 indexed citations
15.
Zhang, Dahai, Andrea Wan, Amy P. Chiu, et al.. (2013). Hyperglycemia-Induced Secretion of Endothelial Heparanase Stimulates a Vascular Endothelial Growth Factor Autocrine Network in Cardiomyocytes That Promotes Recruitment of Lipoprotein Lipase. Arteriosclerosis Thrombosis and Vascular Biology. 33(12). 2830–2838. 38 indexed citations
16.
Puthanveetil, Prasanth, Dahai Zhang, Ying Wang, et al.. (2012). Diabetes triggers a PARP1 mediated death pathway in the heart through participation of FoxO1. Journal of Molecular and Cellular Cardiology. 53(5). 677–686. 56 indexed citations
17.
Puthanveetil, Prasanth, Andrea Wan, & Brian Rodrigues. (2012). FoxO1 is crucial for sustaining cardiomyocyte metabolism and cell survival. Cardiovascular Research. 97(3). 393–403. 120 indexed citations
18.
Wanniarachchi, Yoshitha A., Piotr Kaczmarek, Andrea Wan, & Elizabeth M. Nolan. (2011). Human Defensin 5 Disulfide Array Mutants: Disulfide Bond Deletion Attenuates Antibacterial Activity against Staphylococcus aureus. Biochemistry. 50(37). 8005–8017. 54 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026